Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Humanized anti-KSA monoclonal antibody - human interleukin-2 fusion protein

EU orphan designation number: EU/3/02/097
Active ingredient: Humanized anti-KSA monoclonal antibody - human interleukin-2 fusion protein
Indication: Treatment of renal cell carcinoma
Sponsor: Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2002 Centralised Orphan - Designation EMEA/OD/063/01 (2002)1292 of 22/03/2002
28/03/2003 Centralised Orphan - Removal of orphan designation from Community Register